Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
<p>Abstract</p> <p>Background</p> <p>The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the...
主要な著者: | Moon Hyeong-Gon, Yi Jae, Kim Hee, Lee Hea, Lee Kyung-Min, Yi Minju, Ahn Sookyung, Shin Hee-Chul, Ju Ji-hyun, Shin Incheol, Han Wonshik, Noh Dong-Young |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
BMC
2012-12-01
|
シリーズ: | BMC Cancer |
主題: | |
オンライン・アクセス: | http://www.biomedcentral.com/1471-2407/12/585 |
類似資料
-
RSK2 and ERα comrades-in-arms in homeostasis and transformation
著者:: Katarzyna A. Ludwik, 等
出版事項: (2020-11-01) -
Identifying requirements for RSK2 specific inhibitors
著者:: Eric B. Wright, 等
出版事項: (2021-01-01) -
Radiation therapy induces immunosenescence mediated by p90RSK
著者:: Masaki Imanishi, 等
出版事項: (2022-11-01) -
mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation
著者:: Po-Chien Chou, 等
出版事項: (2020-06-01) -
Artemether confers neuroprotection on cerebral ischemic injury through stimulation of the Erk1/2-P90rsk-CREB signaling pathway
著者:: Shuai Li, 等
出版事項: (2021-10-01)